Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - CASH & EQUIVALENTS
Cash & Equivalents HALO - Halozyme Therapeutics, Inc.
116 M
LAST VALUE
-29.67%
2 YEAR CAGR
-0.73%
5 YEAR CAGR
6.56%
10 YEAR CAGR